Blog

Oct 24, 2024, 13:50

We now have biopsy needles required to make a difference – The Max Foundation

The Max Foundation posted the following on LinkedIn:

“One of the significant barriers to accessing treatment for women with advanced breast cancer in low- and middle-income countries is a lack of biopsy needles for diagnostics. Without these essential tools, many women are unable to receive the timely and accurate diagnoses they need.

We are thrilled to announce that, thanks to the generous donation from our partner organization BD, we now have biopsy needles required to make a difference. We plan to distribute the first shipment in Mozambique, Cambodia, and Bhutan soon, where it will help countless women get the care they deserve.”

biopsy needles

Advanced Breast Cancer Bhutan biopsy needles Cambodia cancer cancer treatment Healthcare Access low- and middle-income countries Mozambique OncoDaily Oncology The Max Foundation

FDA approved sotorasib with panitumumab for KRAS G12C-mutated colorectal cancer

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

Karen Knudsen: Clinical trials are the most advanced form of cancer care

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results